molecular-diagnostics | LabMedica International Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
 https://www.labmedica.com Wed, 20 May 2026 18:37:12 +0100 FeedCreator 1.7.2 Expanded DPYD Genotyping Test Supports Safer Chemotherapy Dosing https://www.labmedica.com/molecular-diagnostics/articles/294810710/expanded-dpyd-genotyping-test-supports-safer-chemotherapy-dosing.html A new DPYD genotyping test broadens coverage to 19 variants, delivering same-day results to guide safer chemotherapy dosing. Expanded DPYD Genotyping Test Supports Safer Chemotherapy Dosing - Expanded DPYD Genotyping Test Supports Safer Chemotherapy Dosing Wed, 20 May 2026 14:41:48 +0100 Multi-Omics Profiling Helps Predict BCG Response and Recurrence in Bladder Cancer https://www.labmedica.com/molecular-diagnostics/articles/294810688/multi-omics-profiling-helps-predict-bcg-response-and-recurrence-in-bladder-cancer.html An AI-enabled multi-omics model stratifies high-risk bladder tumors and predicts recurrence and BCG response to guide care. Multi-Omics Profiling Helps Predict BCG Response and Recurrence in Bladder Cancer - Multi-Omics Profiling Helps Predict BCG Response and Recurrence in Bladder Cancer Wed, 20 May 2026 11:36:14 +0100 New Computational Tool Reveals Genetic Driver of Idiopathic Neuropathy https://www.labmedica.com/molecular-diagnostics/articles/294810685/new-computational-tool-reveals-genetic-driver-of-idiopathic-neuropathy.html An AI approach to genome analysis identifies hard-to-detect genetic expansions, improving diagnosis of unexplained neuropathy. New Computational Tool Reveals Genetic Driver of Idiopathic Neuropathy - New Computational Tool Reveals Genetic Driver of Idiopathic Neuropathy Wed, 20 May 2026 00:19:35 +0100 Breast Cancer-Specific Signatures Link Genome Instability to Outcomes https://www.labmedica.com/molecular-diagnostics/articles/294810684/breast-cancer-specific-signatures-link-genome-instability-to-outcomes.html Researchers identify eight breast cancer copy-number signatures to improve detection and guide terapy selection. Breast Cancer-Specific Signatures Link Genome Instability to Outcomes - Breast Cancer-Specific Signatures Link Genome Instability to Outcomes Tue, 19 May 2026 15:54:27 +0100 Whole-Genome MRD Test Detects Early Recurrence in Muscle-Invasive Bladder Cancer https://www.labmedica.com/molecular-diagnostics/articles/294810630/whole-genome-mrd-test-detects-early-recurrence-in-muscle-invasive-bladder-cancer.html A new whole-genome MRD test gains Medicare coverage to detect post-treatment MIBC recurrence months earlier than imaging. Whole-Genome MRD Test Detects Early Recurrence in Muscle-Invasive Bladder Cancer - Whole-Genome MRD Test Detects Early Recurrence in Muscle-Invasive Bladder Cancer Tue, 19 May 2026 15:45:43 +0100